Skip to main content

Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention

Journal of Community Health volume 43, pages 455–458 (2018)Cite this article

Abstract

Human Papilloma Virus (HPV) is the most common sexually transmitted disease with over 14 million infections in 2008. Certain HPV types have been identified in up to 70% of cases of cervical and anal cancers. Despite being safe and effective, HPV vaccination rates remain low. Vaccination and demographic data was collected pre-and post-intervention. Among 13 thru 17-year-old cohort females were significantly more likely to be fully vaccinated. Assessment also found that patients insured by Medicaid were significantly more likely to be fully vaccinated than patients insured privately. Post-intervention vaccination rate is similar to baseline rates. There was non-significant improvement in HPV vaccination coverage after intervention. Male and privately insured patients of Creighton’s Pediatric Clinic have lower HPV vaccination coverage than their counterparts. More direct efforts are needed in vaccination process and policy in the clinic to improve immunization against HPV among children and adolescents.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Bosch, F. X., Broker, T. R., Forman, D., et al. (2013). Comprehensive control of human papillomavirus infections and related diseases. Vaccine, 31 (Supplement 7(0)), H1–H31.

    Article  PubMed  Google Scholar 

  2. Palefsky, J., & Cranston, R. Virology of human papillomavirus infections and the link to cancer. http://www.uptodate.com. Updated October 15, 2014.

  3. Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. The New England Journal of Medicine, 338(7), 423–428.

    CAS  Article  PubMed  Google Scholar 

  4. de Sanjose, S., et al. (2010). Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncology, 11(11), 1048–1056.

    Article  PubMed  Google Scholar 

  5. Markowitz, L. E., Dunne, E. F., Saraiya, M., et al. (2014). Human papillomavirus vaccination: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendations Report, 63(-05), 1–30.

    Google Scholar 

  6. Curtis, C. R., et al. (2014) National human papillomavirus vaccination coverage among adolescents aged 13–17 years—National Immunization Survey–Teen, United States, 2011. MMWR Surveillance Summary, 63 (suppl 2), 61–70.

    Google Scholar 

  7. Stier, E. A., Sebring, M. C., Mendez, A. E., et al. (2015). Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: A systematic review. The American Journal of Obstetrics & Gynecology, 213, 278–309.

    Article  Google Scholar 

  8. Meites, E. (2016) Use of a 2-dose schedule for human papillomavirus vaccination—Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR. Morbidity and Mortality Weekly Report, 65(49), 1405–1408.

    Article  PubMed  Google Scholar 

  9. Rahman, M., Hirth, J. M. & Berenson, A. B. (2017). Adherence to ACIP recommendation for human papillomavirus vaccine among US adolescent girls. Journal of Community Health, 42(2), 385–389.

  10. Farias, C. C., et al. (2016). Factors related to non-compliance to HPV vaccination in Roraima—Brazil: A region with a high incidence of cervical cancer. BMC Health Services Research, 16(1), 417.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Joura, Elmar A., et al. (2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. New England Journal of Medicine, 372(8), 711–723.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Creighton University School of Medicine, Omaha, NE, USA

    M. Varman, C. Sharlin, C. Fernandez & J. Vasudevan

  2. Department of Pediatrics, Creighton University, Omaha, NE, USA

    M. Varman, C. Fernandez & J. Vasudevan

  3. Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA

    C. Wichman

Authors
  1. M. Varman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Sharlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Vasudevan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Wichman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Varman.

Appendix

Appendix

See Tables 1, 2 and 3.

Table 1 HPV vaccination in males and females aged 13 through 17 by number of doses received
Full size table
Table 2 HPV vaccination 3 dose series completion rates in males and females aged 13 through 17 by type of insurance
Full size table
Table 3 HPV vaccination 3 dose series completion rates in males and females aged 13 through 17 by listed zip code
Full size table

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Varman, M., Sharlin, C., Fernandez, C. et al. Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention. J Community Health 43, 455–458 (2018). https://doi.org/10.1007/s10900-018-0467-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-018-0467-3

Keywords

  • HPV
  • Human papilloma virus
  • Cancer
  • Oropharyggneal cancer
  • Genitourinary cancer
  • HPV 9
  • HPV 4
  • Vaccination rate
  • Adolescent vaccination